Saroglitazar for MASLD Cuts Liver Fat in Women With Polycystic Ovary Syndrome

(MedPage Today) — WASHINGTON — Daily treatment with the novel drug saroglitazar significantly reduced liver fat in women with metabolic dysfunction-associated steatotic liver disease (MASLD) and polycystic ovary syndrome (PCOS), the primary…